Poster Session 4
Category: Obstetric Quality and Safety
Poster Session 4
Havilah Reimche-Vu, BS
Medical Student
Loma Linda University School of Medicine
Loma Linda, California, United States
Bo Park, MPH, PhD
Associate Professor
California State University, Fullerton
Fullerton, California, United States
Nida Ali, BS (she/her/hers)
Clinical Research Coordinator III
Loma Linda University Children's Health | Perinatal Institute
Loma Linda, California, United States
Ashra Tugung, CCRP
Clinical Research Coordinator
Loma Linda University Children's Health | Perinatal Institute
Loma Linda, California, United States
Neville Tritch, BS
Medical Student
Loma Linda University School of Medicine
Loma Linda, California, United States
Kriti N. Vedhanayagam, DO
PGY-3 Resident
Loma Linda University
Loma Linda, California, United States
Kevin H. Hu, MD
Loma Linda University
Loma Linda, California, United States
Sergio A. Karageuzian, DO
PGY-2 Resident
Loma Linda University Health
Loma Linda, California, United States
Ilish Gedestad, DO
PGY-1 Resident
Loma Linda University Health
Loma Linda, California, United States
Ruofan H. Yao, MD, MPH
Maternal Fetal Medicine Faculty
Loma Linda University
Loma Linda, California, United States
Among the 3,076,580 individuals analyzed, 45,261 (1.47%) experienced SMM. Women who did not have influenza, asthma, or HTN were the majority (2,980,400; 98.58%), with a reference SMM rate of 1.42%.
Individuals with influenza only (n = 576) had an elevated SMM rate of 12.15% (HR 9.24 [95% CI: 7.31-11.69]). Those with HTN only (n = 14,254) had a SMM rate of 5.62% (HR 5.43 [95% CI: 5.06-5.83]). Individuals with asthma only (n = 80,277) showed a SMM rate of 2.30% (HR 1.48 [95% CI: 1.41-1.55]).
Comorbid conditions were associated with compounding risk. The interaction of flu and asthma (n = 49) resulted in a SMM rate of 16.33% (HR 14.17 [95% CI: 7.09-28.34]). Those with influenza and HTN (n = 7) had an elevated SMM rate of 71.43% (HR 58.17 [95% CI: 24.20-139.82]). Individuals with asthma and HTN (n = 1,016) had a SMM rate of 8.07% (HR 7.31 [95% CI: 5.89-9.08]). The influenza, asthma, and HTN (n = 1) cohort was too small to associate with SMM risk.